Medicare Enrolled

Dr. Indraneel Chakrabarty, M.D.

Internal Medicine · Temecula, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
31625 DE PORTOLA RD STE 101, Temecula, CA 92592
9515014200
In practice since 2007 (18 years)
NPI: 1356558621 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chakrabarty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chakrabarty? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chakrabarty

Dr. Indraneel Chakrabarty is an internal medicine specialist in Temecula, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Chakrabarty performed 2,878 Medicare services across 2,176 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chakrabarty received a total of $53,738 from 47 pharmaceutical and/or device companies across 579 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chakrabarty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 11% volume in CA $53,738 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,878
Medicare services
Top 11% in CA for internal medicine
2,176
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~160 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
695 $64 $184
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
598 $100 $338
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
342 $99 $350
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
281 $78 $585
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
232 $126 $441
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
176 $136 $476
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
157 $114 $828
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
84 $200 $1,505
Dilation of esophagus 74 $33 $208
New patient office visit, complex (60-74 min) 51 $179 $583
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
44 $144 $1,124
Radiologist review of bile duct tube placement imaging
A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope.
31 $19 $74
Endoscopic insertion of stomach tube
A flexible endoscope is used to guide the placement of a tube into the stomach.
25 $165 $524
Endoscopic incision of pancreatic outlet
A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet.
22 $40 $935
Endoscopic ultrasound of esophagus, stomach, or small bowel
An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope inserted through the mouth.
20 $148 $513
Endoscopic removal of bile or pancreatic duct stone
A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts.
20 $276 $952
Endoscopy of digestive tract
Imaging of the digestive tract performed from the inside using an endoscope.
15 $651 $2,140
Ultrasound-guided esophageal needle biopsy
A procedure using a flexible endoscope with ultrasound to guide a needle for sampling tissue from the esophagus.
11 $191 $605
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$53,738
Total received (2018-2024)
Avg $7,677/year across 7 years
Top 3% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
579
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48,758 (90.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,979 (9.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,919
2023
$4,386
2022
$6,888
2021
$5,619
2020
$6,774
2019
$9,403
2018
$15,748

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,912
Gilead Sciences, Inc.
$184
GENZYME CORPORATION
$155
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$96
Janssen Biotech, Inc.
$87
Boston Scientific Corporation
$70
Ardelyx, Inc.
$60
Enterra Medical, Inc.
$57
Takeda Pharmaceuticals U.S.A., Inc.
$39
EVOKE PHARMA, INC.
$38
VIVUS LLC
$33
PFIZER INC.
$27
Phadia US Inc.
$26
Lilly USA, LLC
$24
Ferring Pharmaceuticals Inc.
$22
Axonics, Inc.
$22
Celgene Corporation
$20
Fresenius Kabi USA, LLC
$18
Bayer Healthcare Pharmaceuticals Inc.
$15
Phathom Pharmaceuticals, Inc.
$13
Top 3 companies account for 86.4% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$23,058
AbbVie Inc.
$15,386
ABBVIE INC.
$10,281
Takeda Pharmaceuticals U.S.A., Inc.
$782
Gilead Sciences, Inc.
$563
Allergan Inc.
$493
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$387
GENZYME CORPORATION
$295
Ferring Pharmaceuticals Inc.
$243
Boston Scientific Corporation
$176
Janssen Biotech, Inc.
$173
Janssen Pharmaceuticals, Inc
$125
Phathom Pharmaceuticals, Inc.
$107
Ironwood Pharmaceuticals, Inc
$104
Ardelyx, Inc.
$99
PFIZER INC.
$96
PENTAX of America, Inc.
$84
Shionogi Inc
$81
RedHill Biopharma Inc.
$81
Alfasigma USA, Inc.
$81
ERBE USA Inc
$74
Concordia Pharmaceuticals Inc.
$71
Ethicon US, LLC
$58
Synergy Pharmaceuticals Inc
$58
Regeneron Healthcare Solutions, Inc.
$58
Enterra Medical, Inc.
$57
QOL Medical, LLC
$55
Lilly USA, LLC
$51
EVOKE PHARMA, INC.
$50
IRONWOOD PHARMACEUTICALS, INC
$49
INTERCEPT PHARMACEUTICALS, INC.
$47
Pinnacle Biologics, Inc
$37
Merck Sharp & Dohme Corporation
$36
Intercept Pharmaceuticals, Inc.
$35
Celgene Corporation
$34
VIVUS LLC
$33
Allergan, Inc.
$29
Ambu Inc.
$26
Phadia US Inc.
$26
CONMED Corporation
$26
PORTOLA PHARMACEUTICALS, INC.
$25
Novo Nordisk Inc
$22
Axonics, Inc.
$22
Fresenius Kabi USA, LLC
$18
Medtronic, Inc.
$15
Daiichi Sankyo Inc.
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Top 3 companies account for 90.7% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · AVYCAZ · Acquire · Adempas · Aloka Arietta 850 · Amitiza · Axonics · CIMZIA · CLENPIQ · CREON · Compliance EndoKit · Creon · DALVANCE · DIFICID · DONNATAL · DUPIXENT · Dexilant · Donnatal · ENTYVIO · EOHILIA · EXALT Model D · Entyvio · Epclusa · Erbe VIO3 APC3 · GATTEX · GENERAL - ENDOCHOICE · GIMOTI · General - Polypectomy · HUMIRA · Humira · IBSRELA · IDACIO · IMAGINA · INJECTAFER · ImmunoCAP · LASTACAFT · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOUNJARO · Mavyret · Motegrity · Movantik · Mulpleta · OCALIVA · OMVOH · Photofrin · QSYMIA · REBYOTA · REMICADE · RINVOQ · SKYRIZI · SPYGLASS · STELARA · SUCRAID · Sucraid · Symbotex · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · VIBERZI · VOQUEZNA · VRAYLAR · Wegovy · XARELTO · XELJANZ · XIFAXAN · XIFIXAN · ZENPEP · ZEPOSIA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for internal medicine in CA.

Looking for an internal medicine specialist in Temecula?
Compare internal medicine physicians in the Temecula area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
207
Per 100K population
8.4
County median income
$89,672
Nearest hospital
TEMECULA VALLEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chakrabarty is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with speaking/promotional industry engagement in the top 3% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chakrabarty experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Chakrabarty performed 695 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chakrabarty receive payments from pharmaceutical companies?
Yes. Dr. Chakrabarty received a total of $53,738 from 47 companies across 579 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chakrabarty's costs compare to other internal medicine physicians in Temecula?
Dr. Chakrabarty's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chakrabarty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →